TY - JOUR
T1 - Reactivation of Dormant Relay Pathways in Injured Spinal Cord by KCC2 Manipulations
AU - Chen, Bo
AU - Li, Yi
AU - Yu, Bin
AU - Zhang, Zicong
AU - Brommer, Benedikt
AU - Williams, Philip Raymond
AU - Liu, Yuanyuan
AU - Hegarty, Shane Vincent
AU - Zhou, Songlin
AU - Zhu, Junjie
AU - Guo, Hong
AU - Lu, Yi
AU - Zhang, Yiming
AU - Gu, Xiaosong
AU - He, Zhigang
N1 - Publisher Copyright:
© 2018 Elsevier Inc.
PY - 2018/7/26
Y1 - 2018/7/26
N2 - Many human spinal cord injuries are anatomically incomplete but exhibit complete paralysis. It is unknown why spared axons fail to mediate functional recovery in these cases. To investigate this, we undertook a small-molecule screen in mice with staggered bilateral hemisections in which the lumbar spinal cord is deprived of all direct brain-derived innervation, but dormant relay circuits remain. We discovered that a KCC2 agonist restored stepping ability, which could be mimicked by selective expression of KCC2, or hyperpolarizing DREADDs, in the inhibitory interneurons between and around the staggered spinal lesions. Mechanistically, these treatments transformed this injury-induced dysfunctional spinal circuit to a functional state, facilitating the relay of brain-derived commands toward the lumbar spinal cord. Thus, our results identify spinal inhibitory interneurons as a roadblock limiting the integration of descending inputs into relay circuits after injury and suggest KCC2 agonists as promising treatments for promoting functional recovery after spinal cord injury. Reducing the excitability of spinal cord inhibitory interneurons with a small molecule enhances the injured spinal cord's responsiveness to descending inputs and promotes functional recovery after spinal cord injury in mice.
AB - Many human spinal cord injuries are anatomically incomplete but exhibit complete paralysis. It is unknown why spared axons fail to mediate functional recovery in these cases. To investigate this, we undertook a small-molecule screen in mice with staggered bilateral hemisections in which the lumbar spinal cord is deprived of all direct brain-derived innervation, but dormant relay circuits remain. We discovered that a KCC2 agonist restored stepping ability, which could be mimicked by selective expression of KCC2, or hyperpolarizing DREADDs, in the inhibitory interneurons between and around the staggered spinal lesions. Mechanistically, these treatments transformed this injury-induced dysfunctional spinal circuit to a functional state, facilitating the relay of brain-derived commands toward the lumbar spinal cord. Thus, our results identify spinal inhibitory interneurons as a roadblock limiting the integration of descending inputs into relay circuits after injury and suggest KCC2 agonists as promising treatments for promoting functional recovery after spinal cord injury. Reducing the excitability of spinal cord inhibitory interneurons with a small molecule enhances the injured spinal cord's responsiveness to descending inputs and promotes functional recovery after spinal cord injury in mice.
KW - KCC2
KW - excitability
KW - excitation/inhibition balance
KW - inhibitory neurons
KW - propriospinal pathways
KW - spinal cord injury
UR - http://www.scopus.com/inward/record.url?scp=85049299541&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85049299541&partnerID=8YFLogxK
U2 - 10.1016/j.cell.2018.06.005
DO - 10.1016/j.cell.2018.06.005
M3 - Article
C2 - 30033363
AN - SCOPUS:85049299541
SN - 0092-8674
VL - 174
SP - 521-535.e13
JO - Cell
JF - Cell
IS - 3
ER -